Home

PHILIPPE SCHAISON

CIK 1637140 · EVP, President Allergan Med · last filed 2025-11-17

PHILIPPE SCHAISON is an EVP, President Allergan Med who has filed 11 SEC Form 4 insider transactions across 4 companies since 2015. The most recent filing, for SKIN, was dated Nov 17, 2025. Across all open-market trades the lifetime net is +$100.0K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $471.2K across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$471.2K

Companies

4

Total Filings

11

Lifetime Open-Market Net

$100.0K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
SKIN Director 57,692 $0.68 $39.0K $0 1 2025-11-17
Sientra, Inc. (SIEN) Delisted Director 22,736 $0.17 $4.0K $100.0K 8 2023-06-20
Allergan plc (AGN) Delisted EVP, President Allergan Med 8,620 — — $0 1 2016-06-08
ACT See Remarks 8,620 $50.13 $432.1K $0 1 2015-03-19

Recent Filings

11 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2025-11-17 SKIN Grant (A) +57,692 $0 EDGAR
2023-06-20 Sientra, Inc. (SIEN) Delisted Grant (A) +12,000 $0 EDGAR
2022-06-13 Sientra, Inc. (SIEN) Delisted Grant (A) +103,306 $0 EDGAR
2021-06-15 Sientra, Inc. (SIEN) Delisted Grant (A) +23,936 $0 EDGAR
2020-06-09 Sientra, Inc. (SIEN) Delisted Grant (A) +27,717 $0 EDGAR
2019-06-18 Sientra, Inc. (SIEN) Delisted Grant (A) +19,320 $0 EDGAR
2018-06-07 Sientra, Inc. (SIEN) Delisted Grant (A) +6,116 $125.0K EDGAR
2018-05-09 Sientra, Inc. (SIEN) Delisted Buy (P) +7,407 $100.0K EDGAR
2017-06-26 Sientra, Inc. (SIEN) Delisted Grant (A) +12,861 $125.0K EDGAR
2016-06-08 Allergan plc (AGN) Delisted — — $0 EDGAR
Showing 1–10 of 11
Page 1 of 2
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.